Here is the short answer to can you use AI for YMYL content: Google does not ban AI-generated content, and it does not ban AI for health, finance, or legal topics either. But the evidence does not support publishing AI output on those topics without review. Studies on medical, financial, and legal AI answers all find real accuracy gaps, and Google applies a higher trust bar to exactly this kind of content. Call the case for caution strongly supported. Call the case for an outright ban weak, because that is not what the evidence or Google's own guidance says.
That distinction matters if you are deciding whether AI belongs anywhere in your health, finance, or legal content pipeline. This article walks through what Google actually says about ai content health finance legal production, why YMYL gets a higher bar in the first place, and what the health, finance, and legal research says about how AI performs on questions in those categories. The goal is to help you weigh the ai generated ymyl seo risk against what AI actually gets right, not to hand you a review checklist. If you have already decided yes and want the execution playbook, that is a separate piece.
What Google actually says about AI and YMYL content
Google's Search Central guidance, published February 8, 2023, makes a distinction that gets lost in most of the debate: it focuses on content quality, not on who or what produced the content. Google's ranking systems reward original, helpful content that shows expertise, experience, authoritativeness, and trustworthiness, and they do not care whether a person or a model typed the words. AI or automation is fine when it is used to create something genuinely useful. It becomes a problem when automation exists mainly to manipulate rankings, which is a spam violation regardless of the tool used to do it.
Google's current documentation on generative AI content, last updated December 10, 2025, repeats the point and adds a warning: generative AI can help with research and can help structure original content, but generating a large volume of pages without adding real value to readers can trigger the scaled-content-abuse policy. The guidance tells publishers to focus on accuracy, quality, and relevance, especially when content is produced automatically.
The March 5, 2024 spam-policy update sharpened this further. Scaled-content abuse applies no matter how the content was made, whether by AI, by a team of human writers, or some mix of both. The issue is not the presence of AI. It is scale without value, content built to game rankings instead of help the reader. A human-written article created purely to rank, with nothing useful to say, gets the same treatment as an AI-generated one that does the same thing.
Put together, these three pieces of guidance settle the headline question. AI is not automatically against Google's rules, and it gets no special ranking boost either. Content made with AI is judged as content, the same as anything else. That is the part of the debate that is actually confirmed. What is not confirmed is that AI-assisted YMYL content is safe to publish just because it clears that bar, and that is where the domain-specific evidence comes in.
Why YMYL content gets a higher quality bar
YMYL stands for Your Money or Your Life, and Google's Search Quality Rater Guidelines, updated September 11, 2025, define it by consequence rather than by topic label. A page qualifies as YMYL Health or Safety if it could affect someone's physical, mental, or emotional health. It qualifies as YMYL Financial Security if it could affect a person's ability to support themselves or their family. There is also a YMYL Government, Civics and Society category, and a catch-all YMYL Other for anything that could hurt people or damage societal wellbeing.
The guidelines are explicit that even small inaccuracies in this kind of content can carry outsized consequences. Getting a recipe wrong is a bad dinner. Getting a dosage, an investment allocation, or a legal deadline wrong can genuinely hurt someone. That asymmetry is the entire reason the bar moves. The guidelines say clear YMYL topics need accurate information to avoid harm, and that giving advice on them may require real expertise to be considered trustworthy at all.
Trust sits at the center of the E-E-A-T framework the raters use, and trust here means something specific: is the page accurate, honest, safe, and reliable. Pages that are harmful, deceptive, or untrustworthy get the lowest quality rating available, and pages containing information that could actually hurt someone are flagged separately as harmfully misleading. This reframes the question people usually ask. YMYL content does not get extra scrutiny because it was written by AI. It gets extra scrutiny because the cost of being wrong is higher, and AI can raise that cost when it produces something that sounds right but is not, skips a caveat that matters, or states an uncertain answer with total confidence.
One nuance worth flagging: Google says the rater guidelines exist to help human raters judge how well its ranking systems are already performing, not to directly set an individual page's rank. They describe the standard Google wants its algorithms to hit, not proof that a person manually reviewed your specific article. On legal content specifically, the current rater guideline text does not name legal as its own labeled YMYL category the way it names health and financial security. Legal information clearly falls under the broader YMYL Other umbrella given its consequences, but you should not claim Google has a legal-specific YMYL classification when the source document does not say that.
What the health evidence shows
The clearest test of AI on patient-facing health questions comes from a study published July 13, 2024 by Rodrigo Anguita and colleagues, evaluating how ChatGPT 3.5, Bing AI, and DocsGPT answered questions about choroidal melanoma, a rare eye cancer. Three ocular oncology specialists graded 27 answers across two categories: general medical-advice questions and pre- and post-operative questions.
On the medical-advice questions, ChatGPT produced accurate and sufficient answers 92 percent of the time. Bing AI and DocsGPT each landed at 58 percent on the same set of questions, a meaningful gap between models answering the exact same prompts. On the operative questions, ChatGPT and Bing AI both reached 86 percent accuracy, while DocsGPT came in at 73 percent. Every model correctly told patients to talk to their doctor, a real point in AI's favor. But four answers across the set were flatly inaccurate, and when the researchers repeated the same questions, answers varied 57 percent of the time between runs. Ask the same model the same question twice and you may not get the same answer twice, which is its own kind of risk in published content.
A much larger 2025 systematic review and network meta-analysis, published in the Journal of Medical Internet Research on April 30, 2025, screened close to 59,000 citations and pulled together 168 studies on how large language models handle medical questions and clinical cases. The picture is not one model winning across the board. ChatGPT-4o performed best on objective questions in the pooled evidence, ChatGPT-4 did better on open-ended questions, Claude 3 Opus did better on top-five diagnosis tasks, and Gemini did better on some classification tasks. Human clinicians still outperformed every model on top-one and top-three diagnosis accuracy in the studies reviewed. The authors' own conclusion is not that models are ready to stand in for doctors, but that models should support clinical judgment, not replace it, since performance varies enough by task and model that no single number describes "AI accuracy" for medicine.
It is worth naming the evidence that looks better than it is. A benchmark study from October 2024 tested five models against 1,181 expert-level critical-care multiple-choice questions, and GPT-4o scored 93.3 percent, ahead of four physicians on a practice exam. Med-PaLM 2 has separately been reported at 86.5 percent on USMLE-style questions. Those are real, structured results, but a multiple-choice exam score measures something different from safe, publishable, patient-facing writing. An exam question has one correct answer and no ambiguity about scope, sourcing, or omission. A published health article has to choose what to include, what to leave out, how to qualify uncertainty, and who the advice is safe for, none of which a benchmark tests. The same study notes the models it tested can still be overconfident and can carry cognitive biases inherited from training data. A high score on a test is not evidence that the same model writes something safe to publish unedited.
The World Health Organization's January 18, 2024 guidance on large multimodal models in health care adds the governance layer to this picture. It lays out more than 40 recommendations for governments, tech companies, and health providers, and flags a specific risk: models that imitate human communication convincingly enough that people trust them for tasks they were never validated to perform, especially when the underlying training data carries its own quality or bias problems. The guidance is not a study of content rankings, but it backs up the throughline of every study above. Fluency and reliability are two different things.
What the finance evidence shows
The clearest data point on AI and financial content comes from a study by Gianni Nicolini, Brenda J. Cude, and Swarn Chatterjee published in June 2026, testing whether seven widely used generative AI tools give consistent, fair financial recommendations. The tools tested were ChatGPT 4.1 Mini, Claude 3.5 Sonnet, Gemini 2.5 Flash, Copilot Think Deeper, DeepSeek V3, Meta AI running Llama 3.1-405B, and Perplexity using Sonar, all queried with standardized prompts during the same week in August 2025.
The researchers ran three scenarios: how much to hold in emergency savings, what a sustainable retirement withdrawal rate looks like, and how to allocate an investment portfolio, also varying the stated race and gender of the household in the prompt to test for bias. The results diverged more than you might expect from tools answering the same underlying questions. Emergency-fund recommendations ranged from three to six months of expenses up to six to 12 months, and the suggested dollar amounts ranged from $21,000 to $37,500 depending on the tool. Claude consistently recommended the highest amount, Meta AI the lowest, and the difference between tools was statistically significant. Portfolio allocation showed a similar spread, with recommended equity allocations ranging from 15 percent to 45 percent across tools for the same scenario. Retirement withdrawal rates were the one area where tools mostly agreed, clustering around the traditional 4 percent rule with no significant differences found. On the bias question, some tools held steady across the different household descriptions while others changed their recommendations, which the researchers flag as a fairness issue worth further study.
The question of whether should AI write medical or financial content sits right at the center of this study's design, and two things about it deserve to stay attached to the numbers. First, it tested personalized financial recommendations to a specific household scenario, not the accuracy of a generic finance blog article, so the results describe advice-giving behavior rather than editorial content quality. Second, the researchers themselves note their results could shift with different prompts or household details, and that these models are still evolving. Their broader point stands regardless: outputs can sound confident while being incomplete, misleading, or simply wrong, and that gap between confidence and correctness is exactly the risk a financial content pipeline needs to plan around.
The study does point to one place AI clearly helps without the same risk: drafting routine communications a financial-planning practice sends out, emails, newsletters, social copy, none of which carries the same weight as a specific recommendation about someone's money. That distinction, between AI drafting marketing communication and AI generating financial guidance a reader might act on, is worth carrying into your own editorial decisions. Separately, any health claim used in commercial or advertising content, AI-written or not, still has to meet the FTC's substantiation standard for health claims, which requires solid scientific support behind the claim. AI authorship does not change that obligation.
What the legal evidence shows
Legal content has the starkest numbers of the three categories, from two separate 2024 studies that used different methods and landed on similarly troubling results. The first, from Stanford's RegLab and Institute for Human-Centered AI, reported by Matthew Dahl and colleagues on January 11, 2024, ran more than 200,000 queries against GPT-3.5, Llama 2, and PaLM 2, on questions ranging from simple lookups (who wrote this opinion) to genuinely hard legal reasoning (are these two cases in tension, and what did the court hold). Across specific legal queries, hallucination rates ranged from 69 to 88 percent. On the hardest task, identifying the actual holding of a case, models hallucinated at least 75 percent of the time. Performance got worse, not better, as questions required more legal nuance, and models frequently showed no awareness they had gotten something wrong, sometimes reinforcing a user's incorrect assumption rather than correcting it.
The second study, Large Legal Fictions by Matthew Dahl and Varun Magesh, published in the Journal of Legal Analysis on June 26, 2024, took a different approach: sampling 5,000 cases from each level of the federal judiciary and asking open-domain legal questions the way a self-represented person might type them into a chat interface. This study found a hallucination rate of at least 58 percent, using reference-based and reference-free methods to catch both factual errors and unsupported claims.
These two numbers, 69 to 88 percent and 58 percent, are not contradicting each other. They come from different samples, different task structures, and different ways of counting a hallucination, and both studies caution against treating their number as a universal rate for every model or every kind of legal question. What they agree on is the direction of the finding: current models are not yet doing the kind of precedent-aware legal reasoning that a working attorney does, and they get noticeably worse exactly where legal accuracy matters most, on the complex, high-stakes questions rather than the simple lookups. Both research teams recommend caution and supervised use rather than treating a fluent-sounding legal answer as a correct one.
The verdict: where the evidence leaves the reader
The question of whether is AI content risky for YMYL topics does not have one clean answer, but bringing the three threads together makes the shape of the risk clear even though the numbers come from different fields. Google does not prohibit AI-assisted YMYL content, and there is no evidence here of a blanket ranking penalty triggered by AI authorship alone. At the same time, none of the studies in health, finance, or legal content support treating unreviewed AI output as safe to publish on a topic where getting it wrong can hurt someone. The health studies show real variability and real inaccuracies even where average accuracy looked decent. The finance study shows recommendations that shift meaningfully by tool and, in some cases, by the demographic details in the prompt. The legal studies show hallucination rates high enough that a fluent, confident-sounding answer is not evidence the answer is correct.
None of the research reviewed here tested the actual workflow most teams would use in practice: AI drafting followed by a qualified human reviewing every material claim before publication. That is a real gap, and it means the evidence does not prove that workflow is safe either, only that the question those studies actually answer is narrower than the debate around them usually treats it as. The honest verdict is not "AI can't touch YMYL content" and it is not "AI is fine, publish what it gives you." The risk lives specifically in unreviewed output, and every study above found errors a subject-matter expert would have caught before publication. Treat the model's fluency as writing quality, not as a fact check. The question for your pipeline stops being whether AI touched the draft and becomes whether the finished piece is accurate, useful, and safe for whatever it tells someone to do with their health, money, or legal situation.
